How Vascular Endothelial Growth Factor-A (VEGF) Regulates Differentiation of Mesenchymal Stem Cells

被引:72
作者
Berendsen, Agnes D. [1 ]
Olsen, Bjorn R. [1 ]
机构
[1] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
VEGF; bone remodeling; osteoblast; transcription; skeletal development; TYROSINE KINASE; BONE-DEVELOPMENT; FACTOR RECEPTORS; SURVIVAL; FLT-1; MICE; VASCULOGENESIS; ANGIOGENESIS; OSTEOBLAST; LETHALITY;
D O I
10.1369/0022155413516347
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vascular endothelial growth factor A (VEGF), a key factor in angiogenesis, plays an essential role in skeletal development and postnatal homeostasis. VEGF serves as a survival factor for chondrocytes and couples the resorption of cartilage with bone formation during endochondral ossification. Recently, it has also been found to regulate the balance between osteoblast and adipocyte differentiation in bone marrow mesenchymal stem cells. Surprisingly, this regulatory function of VEGF is not based on paracrine signaling involving cell surface receptor activation. Instead, the mechanism appears to utilize intracellular VEGF, which is functionally linked to the nuclear envelope protein lamin A. Lamin A and VEGF control osteoblast and adipocyte differentiation by regulating the levels of the osteoblast and adipocyte transcription factors Runx2 and PPAR, respectively. These data raise the intriguing possibility that loss of bone mass during aging may be manipulated by controlling the levels and activity of intracellular VEGF in bone marrow mesenchymal stem cells.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 29 条
  • [1] Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
    Barleon, B
    Sozzani, S
    Zhou, D
    Weich, HA
    Mantovani, A
    Marme, D
    [J]. BLOOD, 1996, 87 (08) : 3336 - 3343
  • [2] Carmeliet P, 1999, CURR TOP MICROBIOL, V237, P133
  • [3] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [4] THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR
    DEVRIES, C
    ESCOBEDO, JA
    UENO, H
    HOUCK, K
    FERRARA, N
    WILLIAMS, LT
    [J]. SCIENCE, 1992, 255 (5047) : 989 - 991
  • [5] Ferrara N, 1997, EXS, V79, P209
  • [6] Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
    Ferrara, N
    CarverMoore, K
    Chen, H
    Dowd, M
    Lu, L
    OShea, KS
    PowellBraxton, L
    Hillan, KJ
    Moore, MW
    [J]. NATURE, 1996, 380 (6573) : 439 - 442
  • [7] ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM
    FONG, GH
    ROSSANT, J
    GERTSENSTEIN, M
    BREITMAN, ML
    [J]. NATURE, 1995, 376 (6535) : 66 - 70
  • [8] VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
    Gerber, HP
    Vu, TH
    Ryan, AM
    Kowalski, J
    Werb, Z
    Ferrara, N
    [J]. NATURE MEDICINE, 1999, 5 (06) : 623 - 628
  • [9] VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism
    Gerber, HP
    Malik, AK
    Solar, GP
    Sherman, D
    Liang, XH
    Meng, G
    Hong, K
    Marsters, JC
    Ferrara, N
    [J]. NATURE, 2002, 417 (6892) : 954 - 958
  • [10] Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
    Hiratsuka, S
    Minowa, O
    Kuno, J
    Noda, T
    Shibuya, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9349 - 9354